New Trial Data Show Positive Results for Treating Thyroid Eye Disease

July 31, 2020

Two clinical trials have shown positive topline data that add to the growing body of evidence supporting the efficacy and safety of teprotumumab-trbw for the treatment of Thyroid Eye Disease (TED). Horizon Therapeutics is marketing the drug as TEPEZZA, the first medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of […]

To view the full Member Resource, please Log in

TOPICS IN THIS ARTICLE:

←Long-Term Culture of Human Pancreatic Slices Reveals the Regeneration of Insulin-Producing Cells in Real Time

More Connected, United, and Inclusive Than Ever→

View Archives

Join the Global Movement Advancing Endocrine Science and Medicine

Become a part of a community of 18,000-plus endocrine investigators and clinicians who conduct research and provide quality patient care in more than 100 countries. Advance your career and the field of endocrinology through our many educational, leadership and advocacy opportunities.

Join Today